Search the Newsreel

Elanco Animal Health Q2 Earnings Call Highlights

Key Points Interested in Elanco Animal Health Incorporated? Here are five stocks we like better. Strong Q2 performance: Elanco reported revenue of $1.368 billion, up 10% year over year, while adjusted EBITDA rose 21% to $288 million and adjusted EPS increased 31% to $0.34. …

elanco animal health inc. Positive Earnings Pre-Announcements

Elanco Animal Health Inc. (ELAN) has pre-announced positive earnings for FY26, with an updated estimated range of $5.090-$5.140 Billion, up from $5.010-$5.085 Billion. This follows a recent boost in their FY26 outlook and a 7% stock increase reported on August 5, 2026. The company …

Amalgamated Bank (NASDAQ: AMAL) Share Price, AMAL Stock News, AMAL Share Price & Updates

Aarti Pharmalabs director Rajendra Gogri steps down

Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species

Vigilance and early intervention are key to minimizing animal injury and limiting the parasite's spread, according to Elanco's technical experts Emergency Use Authorization for Elanco's CLiK Extra provides livestock producers with a vital tool in the prevention of New World screwworm infestations. Elanco also …

GuocoLand Malaysia Completes Privatisation via Capital Reduction

İNTEMA İNŞAAT VE TESİSAT MALZEMELERİ YATIRIM VE PAZARLAMA A.Ş.(INTEM) Katılım Finansı İlkeleri Bilgi Formu 7 Ağustos 2026

Elanco Ends Lobbying Relationship With Stumptown Strategies

Elanco Animal Health Inc. has terminated its lobbying contract with Stumptown Strategies LLC, a firm it paid approximately $10,000 per quarter. The company, which had Blair Larkins as its primary lobbyist, has been advocating for the Innovative FEED Act, legislation aimed at reclassifying certain …

Elanco granted FDA’s emergency nod for new world screwworm drug

[US Food and Drug Administration (FDA)] * The U.S. Food and Drug Administration has granted an emergency use authorization for Elanco Animal Health’s (ELAN [https://seekingalpha.com/symbol/ELAN]) antiparasitic therapy CLiK Extra as a treatment to prevent new world screwworm infestations. * The authorization came after the …

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?

Glennon Small Companies Updates Unaudited NTA as at 6 August 2026

Mallcom (India) Standalone June 2026 Net Sales at Rs 108.18 crore, down 8.66% Y-o-Y

Sin Heng Chan Berhad Reports Production Results for the Month of July 2026

Amundi Has $2.35 Million Stock Holdings in Elanco Animal Health Incorporated $ELAN

Thirumalai Chemicals posts ₹142 cr standalone profit in Q1FY27 as US plant nears completion

Phibro Animal Health (PAHC) CFO sells 840 shares to cover taxes

Phibro Animal Health's CFO, David Glenn, disposed of 840 shares of Class A Common Stock on August 4, 2026, at an average price of $36.599 per share. This transaction was a broker-assisted cashless exercise performed to satisfy tax withholding obligations related to the vesting …

Phibro Animal Health (NASDAQ: PAHC) COO sells 635 shares for tax withholding

Phibro Animal Health's Chief Operating Officer, Larry Lee Miller, sold 635 shares of Class A Common Stock on August 4, 2026, at a price of $36.599 per share. This transaction was a broker-assisted cashless exercise to cover tax withholding obligations associated with the vesting …

Phibro Animal Health (NASDAQ: PAHC) GC sells 472 shares for taxes

Phibro Animal Health's General Counsel, Judith Weinstein, sold 472 shares of Class A Common Stock on August 4, 2026, at $36.599 per share. This transaction was a broker-assisted cashless exercise to cover tax withholding obligations upon the vesting of restricted stock units. Following this …

Elanco Animal Health Inc (ELAN) Shares Fall 7.7% -- What GF Score of 66 Tells Investors

Elanco Animal Health Inc (ELAN) shares recently fell 7.7% to $24.20, making it 8.5% down for the week. The stock is currently deemed significantly overvalued with a GF Value™ of $15.62, despite having an above-average GF Score™ of 66/100. While insider activity shows purchases, …

Bursa Malaysia Berhad 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:BSMAF) 2026-08-06

Amalgamated Financial (AMAL) Stock Ignores Record Profit As Cost Risks Linger

Amalgamated Financial (AMAL) reported record Q2 net income of US$34.8 million and a strong return on tangible common equity above 16%, yet its stock saw only a modest 1% gain. The article explores whether this muted market reaction signifies healthy skepticism regarding lingering cost …

Elanco CEO on Boosted Forecast, Surge in Tick Bites

Elanco Animal Health President and CEO Jeff Simmons discusses what's behind the company's increased profit and revenue forecasts. Speaking on "Bloomberg The Close," Simmons also comments on the recent surge in tick bites and consumer spending on pet health products. View Comments

Elanco raises 2026 outlook after strong second-quarter results

Elanco Animal Health Inc. reported a 10% increase in second-quarter revenue to $1.37 billion, leading the company to raise its full-year financial guidance for the second time. The growth was attributed to strong performance of new products like Zenrelia and Credelio Quattro, as well …

FMR LLC discloses 15% ownership of Phibro Animal Health (PAHC) Class A shares

FMR LLC and Abigail P. Johnson have reported a 15.0% beneficial ownership stake in Phibro Animal Health Corp's Class A common stock, totaling 3,160,280.92 shares as of June 30, 2026. FMR LLC holds sole voting power over 3,159,853 shares and sole dispositive power over …

Why Elanco Animal Health (ELAN) Stock Is Down Today

ADUS vs. ELAN: Which Stock Is the Better Value Option?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and Elanco Animal Health Incorporated (ELAN). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take …

UBS Adjusts Price Target on Elanco Animal Health to $33 From $31, Maintains Buy Rating

UBS has increased its price target for Elanco Animal Health to $33 from $31, while reiterating a Buy rating on the stock. This adjustment follows Elanco's Q2 2026 earnings call, where the company reported rising adjusted earnings and revenue and lifted its 2026 outlook. …

TOURMALINE ANNOUNCES RENEWAL OF NORMAL COURSE ISSUER BID

CALGARY, AB, Aug. 6, 2026 /CNW/ -- Tourmaline Oil Corp. (TSX: TOU) ("Tourmaline" or the "Company") is pleased to announce that the Toronto Stock Exchange (the "TSX") has approved the renewal of Tourmaline's normal course issuer bid (the "NCIB").Tourmaline Oil Corp. Logo The NCIB …

MRT Corp awards $740m contract for Penang Mutiara LRT line

Malaysia Rapid Transit Corporation (MRT Corp) has awarded a RM3.028bn ($740m) system turnkey contract to the joint venture (JV) between Malaysian Resources Corporation Berhad (MRCB) and Theta Edge for the Penang Mutiara Light Rail Transit (LRT) Line. This step marks the beginning of the …

Dimensional Fund Advisors LP Purchases 52,635 Shares of Malibu Boats, Inc. $MBUU

UBS Group Boosts Elanco Animal Health (NYSE:ELAN) Price Target to $33.00

Empowered Funds LLC Acquires Shares of 89,548 Malibu Boats, Inc. $MBUU

Heineken Malaysia tumbles as Q2 profit plunges nearly 40%

Tourmaline Oil Corp. (TSE:TOU) Receives Average Recommendation of "Moderate Buy" from Brokerages

Himalaya Shipping Ltd. (HSHP) – Invitation to Second Quarter 2026 Conference Call

Himalaya Shipping Ltd. (HSHP) announced an invitation to its Second Quarter 2026 Conference Call, scheduled for Tuesday, August 11, 2026, at 9:00 a.m. Eastern Time (3:00 p.m. CET). The company plans to release its financial results for the second quarter of 2026 before the …

Heineken Malaysia's Profit Plunges 39% in Q2